Dear Sir, With interest we read the letter by Montenegro et al. concerning the relation between lipoprotein(a) [Lp(a)] levels and peritoneal albumin losses. Their findings of lack of a significant correlation between Lp(a) levels vs. plasma albumin, peritoneal or total albumin losses, are in apparent contradiction to our previous findings, where we reported significant correlations between Lp(a) vs. peritoneal and total clearance as well as excretion for albumin and ß2-microglobulin [1]. In addition, we found a relation between Lp(a) levels and peritoneal glucose absorption [1]. We wish to emphasize that the correlation coefficients of 0.35-0.50 in our study indicate that the above factors only would account for a minor part (10-25%) of the observed variation in Lp(a) levels. Apart from our study, others have investigated the relation between Lp(a) levels and peritoneal losses. In a study of 64 CAPD patients by Wanner et al.
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